Cytek Biosciences, Inc.
CTKB
$3.96
$0.195.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.87M | -44.08M | -5.48M | -5.58M | -11.40M |
| Total Depreciation and Amortization | 2.81M | 3.04M | 3.06M | 2.99M | 2.88M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.32M | 43.74M | 2.08M | 3.49M | 5.36M |
| Change in Net Operating Assets | 9.00M | -3.48M | -3.56M | -785.00K | 3.03M |
| Cash from Operations | -2.74M | -771.00K | -3.90M | 108.00K | -125.00K |
| Capital Expenditure | -2.17M | -1.00M | -657.00K | -1.58M | -849.00K |
| Sale of Property, Plant, and Equipment | 6.00K | 195.00K | 1.00K | 23.00K | 33.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.92M | -1.04M | 19.58M | -14.86M | 10.27M |
| Cash from Investing | -27.08M | -1.84M | 18.92M | -16.41M | 9.45M |
| Total Debt Issued | 5.07M | 1.42M | 2.09M | 1.39M | 690.00K |
| Total Debt Repaid | -869.00K | -2.94M | -145.00K | -142.00K | -1.52M |
| Issuance of Common Stock | 21.00K | 531.00K | 137.00K | 767.00K | 39.00K |
| Repurchase of Common Stock | -239.00K | -234.00K | -142.00K | -4.61M | -10.76M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 1.00K | -- | -- | -- |
| Cash from Financing | 3.98M | -1.23M | 1.94M | -2.60M | -11.55M |
| Foreign Exchange rate Adjustments | 646.00K | 1.41M | 846.00K | -921.00K | -1.23M |
| Miscellaneous Cash Flow Adjustments | -- | -- | 1.00K | -1.00K | -- |
| Net Change in Cash | -25.19M | -2.43M | 17.81M | -19.83M | -3.45M |